It’s out! We are delighted to announce that we have published the 8th edition of the Guide to EU & UK… twitter.com/i/web/status/1…

The CJEU has provided welcome new guidance on when parallel importers can rebrand generic medicines with the origin… twitter.com/i/web/status/1…

It was a pleasure to host the @BIA_UK Women in Biotech London event at our office last night. Fantastic speakers an… twitter.com/i/web/status/1…

RT @twobirdsIP: We are sponsoring LSPN Europe in London on 29th November! Join Chris de Mauny where he will be talking about the latest on…

The UK’s Medicines & Healthcare products Regulatory Agency (MHRA) has recently announced the introduction of a 12-m… twitter.com/i/web/status/1…

The European Commission has proposed new rules to increase safety and quality of substances of human origin, which… twitter.com/i/web/status/1…

The French Clinical Trial Agreement templates were recently updated to ensure #GDPR compliance and have now been tr… twitter.com/i/web/status/1…

We have a few spaces left! Join us for our Life Sciences Academy event this Thurs 22 Sept at our London office. We… twitter.com/i/web/status/1…

Join us for our Digital Health event on 20 Oct in Brussels. With guest speakers from Amazon, IQVIA, Takeda, Novarti… twitter.com/i/web/status/1…